Ποια είναι η τιμή για Athens Medical C.S.A. (IATR)

Η τιμή για Athens Medical C.S.A. (IATR) είναι $1.90

Ποια είναι η κεφαλαιοποίηση αγοράς για Athens Medical C.S.A. (IATR)

Η κεφαλαιοποίηση αγοράς για Athens Medical C.S.A. (IATR) είναι $164.61M

Athens Medical C.S.A. (IATR) Τιμή και Κεφαλαιοποίηση Αγοράς

Athens Medical C.S.A., together with its affiliated companies, operates and holds ownership of hospital facilities both within Greece and on an international scale. The organization delivers extensive diagnostic and treatment options for various cancers, such as those affecting the breast, gastrointestinal system, blood, liver and pancreas, lungs, prostate, skin, bladder, kidneys, and female reproductive organs. Additionally, it offers advanced robotic surgery, neurosurgical procedures, spinal operations, and therapies for cardiac ailments. Its services encompass a broad range of orthopedic specialties, addressing conditions of the foot and ankle, hand and wrist, hip, knee, shoulder, and spine, in addition to treating sports-related injuries. The company also provides care for chronic conditions including diabetes, endocrine disorders, heart failure, high blood pressure, pain management, respiratory system issues, stroke, and thyroid conditions. Furthermore, Athens Medical C.S.A. runs wellness and preventative health centers and performs cosmetic and reconstructive plastic surgery. The group is also involved in medical education, training, and practical service provision, alongside offering patient care guidance. It currently manages eight hospital units, which collectively feature 1,200 beds. Founded in 1984, Athens Medical C.S.A. is headquartered in Athens, Greece.

Η τιμή για IATR	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$59,404.16 $164.61M	NVDA	$5.152T	+3,129,979.26%
$52,308.31 $164.61M	AAPL	$4.537T	+2,756,090.21%
$48,060.33 $164.61M	GOOG	$4.169T	+2,532,258.97%
$41,993.46 $164.61M	MSFT	$3.642T	+2,212,587.79%
$32,336.05 $164.61M	AMZN	$2.805T	+1,703,726.74%

Η τιμή για IATR

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$59,404.16 $164.61M